Short Daily Versus Conventional Hemodialysis for COVID-19 Patients: A Randomized Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 47
- 试验地点
- 1
- 主要终点
- ICU add
研究概览
简要总结
Treatment of dialysis patients involved with COVID-19 with short daily hemodialysis has been supposed to improve short term outcome. It is unclear if short daily dialysis would optimize mortality or ICU admission in routine dialysis patients with COVID-19.
Also the potential variants according with worse outcomes remain to be fully elucidated.
详细描述
investigators undertook a randomized trial in ESRD patients infected with COVID-19 to determine: 1) if short-daily hemodialysis is associated with a reduction in mortality and ICU admission in one weak period and; 2) the potential effective variants in worst outcome. . Paperwork for the trial was submitted to the shaheed beheshti university of medical sciences in June 2021 for registration . The protocol for this trial and supporting CONSORT checklist are available. The SBMU Ethics Board approved the study and all amendments. The study was conducted according to the Declaration of Helsinki.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •ESRD patients >3months on hemodialysis admitted for COVID-19
排除标准
- •ESRD patients <3 months on hemodialysis infected with COVID-19
结局指标
主要结局
ICU add
时间窗: From date of randomization until the date of first documented progression or date of death
admission to ICU or not
Mortality
时间窗: From date of randomization until the date of first documented progression or date of death
discharged or dead
次要结局
未报告次要终点
研究者
nooshin dalili
Assistant Professor
Shahid Beheshti University of Medical Sciences